Haploid cells are amenable for genetic analysis. Recent success in the derivation of mouse haploid embryonic stem cells (haESCs) via parthenogenesis has enabled genetic screening in mammalian cells. However, successful generation of live animals from these haESCs, which is needed to extend the genetic analysis to the organism level, has not been achieved. Here, we report the derivation of haESCs from androgenetic blastocysts. These cells, designated as AG-haESCs, partially maintain paternal imprints, express classical ESC pluripotency markers, and contribute to various tissues, including the germline, upon injection into diploid blastocysts. Strikingly, live mice can be obtained upon injection of AG-haESCs into MII oocytes, and these mice bear haESC-carried genetic traits and develop into fertile adults. Furthermore, gene targeting via homologous recombination is feasible in the AG-haESCs. Our results demonstrate that AG-haESCs can be used as a genetically tractable fertilization agent for the production of live animals via injection into oocytes.
INTRODUCTION
In sexually reproductive organisms, haploid gametes-eggs and sperm-mediate genetic transmission to the next generation. However, both eggs and sperm are structurally specialized for fertilization and cannot divide in vitro, preventing genetic manipulation. An intriguing question is whether haploid cell lines from either sex can be generated, cultured in vitro, and used in place of gametes to create animal models (Kaufman et al., 1983; Yan et al., 2000) . Although mouse haploid embryos have been generated by different strategies in the last three decades (Kaufman, 1978; Latham et al., 2002; Modli nski, 1975; Tarkowski and Rossant, 1976) , embryonic stem cells (ESCs) established from these haploid embryos have turned out to display a diploid karyotype (Kaufman et al., 1983) . In humans, near-haploid cell lines have been established from tumors (Carette et al., 2009; Kotecki et al., 1999; Sukov et al., 2010) , potentially due to the existence of genetic mutations that stabilize the haploid genome. Recently, relatively stable haploid ESCs (haESCs) from mouse parthenogenetic embryos have been established and applied in forward and reverse genetic screens (Elling et al., 2011; Leeb and Wutz, 2011 ). These successes were made possible by the application of 2i culture conditions (Buehr et al., 2008; Nichols et al., 2009a Nichols et al., , 2009b Nichols and Smith, 2011; Ying et al., 2008) , together with haploid cell enrichment using fluorescence-activated cell sorting (FACS) (Elling et al., 2011; Leeb and Wutz, 2011) . However, it is still not clear whether haESCs with a specific genetic trait can be converted into a mouse model either through germline transmission after injection into blastocysts or through direct combination with gametes of the opposite sex. Furthermore, it is critical that these resultant mice can produce progeny themselves and deliver the genetic traits to the next generation. We reasoned that, if haESCs could be generated from androgenetic (AG) blastocysts and stably maintained in vitro, then they might be used to create mouse models simply by injecting these haESCs into oocytes, a procedure that is similar to intracytoplasmic sperm injection (ICSI) .
In this study, we established protocols for the derivation of haESCs from androgenetic blastocysts. These cells display developmental potential in all examined aspects. More significantly, injection of these haESCs into oocytes led to the generation of fertile animals.
RESULTS

Derivation of haESC Lines from Androgenetic Blastocysts
To generate androgenetic haploid mouse embryos, we adopted two different approaches. In the first set of experiments, we performed nuclear transfer (NT), in which a haploid sperm head from Oct4-EGFP transgenic mice (C57BL/6 background), instead of a somatic nucleus, was injected into an enucleated oocyte ( Figure 1A ). The sperm head underwent decondensation and DNA oxidation based on Hoechst staining of the resulting pronucleus and the appearance of a 5-hydroxymethylcytosine (5 hmC) signal (Gu et al., 2011) (Figures 1B and 1C) , reflecting a profound remodeling of the donor nucleus in the enucleated oocytes. Among the 909 oocytes that were reconstructed, 194 (21%) developed into blastocysts in vitro ( Figure 1D ), similar to previously reported efficiency (Latham et al., 2002) . After removal of the zona pellucida, blastocysts were cultured in a standard embryonic stem cell (ESC) culture system supplemented with 2i (Leeb and Wutz, 2011) . Among 34 ES cell lines that were generated, 4 lines (referred to as AGH-OG-1 to AGH-OG-4) were identified and maintained with a subpopulation of haploid cells through multiple rounds of FACS to enrich for haploid cells (Figures 1E and 1F) . In the second set of experiments, androgenetic haploid blastocysts were generated by removal of the female pronucleus from oocytes fertilized by Actin-EGFP transgenic male mice (Figure S1A available online). From 490 manipulated fertilized oocytes, we obtained 82 blastocysts ( Figure S1B ) and generated 5 ES cell lines. After multiple rounds of FACS following passaging in vitro, one haploid ES cell line (referred to as AGH-EG-1) was obtained ( Figures S1C  and S1D ). In summary, we derived 5 AG-haESC lines, which could be expanded in vitro for more than 30 passages. Notably, no AG-haESC line with the Y chromosome was observed in this study ( Figure 1G ), confirming the earlier observations that haploid or diploid Y chromosome-bearing androgenetic embryos could not develop to the blastocyst stage (Latham et al., 2000 (Latham et al., , 2002 . Karyotyping of these ESCs revealed that all of them had a haploid set of 20 chromosomes (Figures 1H and S1E) at different passages (Table S1 ). Comparative genomic hybridization (CGH) of AG-haESC lines confirmed that the haploid cells sustained genome integrity (Figures 1I and S1F and Table S2 ).
Pluripotency of AG-haESCs AG-haESCs showed colony morphology similar to normal diploid mouse ESCs. Immunostaining analysis revealed that ES cell markers, including Nanog, Oct4, Sox2, and SSEA1, were expressed in haES clones ( Figure 2A ) and FACS-derived cells with haploid DNA content ( Figure S2A ). Next, we compared the gene expression profile of AG-haESCs with those of normal ESCs and mouse embryonic fibroblasts (MEFs) from male individuals. To avoid the influence of diploidized cells on the expression profile, we collected samples after FACS of cells in the G1/G0 phase. Clustering of these cells based on microarray expression data showed a high correlation between AG-haESCs and the diploid ESCs, but not MEFs (Figures 2B and S2B) . To test the developmental potential of AG-haESCs, we injected the Oct4-EGFP (AGH-OG)-and Actin-EGFP (AGH-EG)-marked AG-haESCs into diploid blastocysts of ICR origin. AG-haESCs could contribute to the germline, as judged by Oct4-EGFP expression in gonads of day 13.5 embryos ( Figure 2C ). Live-birth chimeric mice with a high degree of somatic contribution by ESCs were derived, and some of these chimeras survived to adulthood (Figure 2D ). To determine whether haploidy can be maintained in chimeras during development, we injected FACS-purified Actin-EGFP-marked AG-haESCs into blastocysts and analyzed the DNA content of progeny of the injected cells at different developmental stages. We found that 2% of the enhanced green fluorescent protein (EGFP)-labeled cells isolated from day 6.5 embryos were still haploid, but no haploid cells could be detected in the embryos at later stages ( Figures S2C-S2E and 2E). We also tested whether haploidy can be maintained upon the differentiation of AG-haESCs in vitro. In vitro differentiation of Oct-EGFP-marked AG-haESCs by retinoic acid treatment for 6 days showed that both the undifferentiated and differentiated populations contained haploid cells (data not shown). These data indicate that haploidy can exist, at least transiently, in differentiated cells. Nevertheless, repeated sorting is essential to maintaining haploidy in ESCs (Elling et al., 2011) . At present, one cannot exclude the possibility that some essential differences may exist between ESCs and somatic cells (Kim et al., 2011) , which could contribute to the maintenance of haploidy in ESCs. Taken together, our results demonstrate that haESCs derived from androgenetic blastocysts, despite showing a tendency of diploidization, are pluripotent as normal diploid ESCs.
Partial Maintenance of Paternal Genomic Imprints in AG-haESCs Because paternal imprints established at the primordial germ cell stage are propagated through fertilization and persist during embryonic development, we next examined whether paternal imprints are maintained in these AG-haESCs. We first compared expression of imprinted genes in the haploid and control diploid ESCs. As expected from the androgenetic origin of AG-haESCs, all paternally imprinted genes, thus maternally expressed genes, were downregulated except for the H19 gene ( Figures 3A and  3B ). In contrast, maternally imprinted genes (expressed from the paternal allele) were upregulated ( Figures 3A and 3B ). These observations suggested that the AG-haESCs largely maintained a typical paternal imprinting status. To further assess epigenetic inheritance, we performed bisulfite sequencing to analyze the methylation profile of two paternally imprinted genes, Gtl2 and H19, and one maternally imprinted gene, Snrpn. Whereas the differentially methylated region (DMR) of H19 retained methylation at a reduced level, methylation at the Gtl2 DMR was largely intact ( Figure 3C ). In contrast, the DMR of the Snrpn gene was free of methylation ( Figure 3C ), reflecting the androgenetic origin of the haploid cells. Methylation at the H19 DMR appeared to be dynamic in cultured AG-haESCs, as the level fluctuated among different passages ( Figure S3 ). It should be noted that loss of imprinting at the H19 locus was also observed in standard diploid mouse and human ESCs upon prolonged culturing (Dean et al., 1998; Humpherys et al., 2001; Rugg-Gunn et al., 2005 . Taken together, parental genomic imprints can be generally maintained in AG-haESCs, albeit more dynamically and less reliably at certain loci.
AG-haESCs Support Development following Injection into Oocytes
We next tested whether AG-haESCs could be used in place of sperm to support full-term development of mouse embryos upon injection into mature oocytes. To this end, we performed intracytoplasmic AG-haESCs injection (ICAHCI) ( Figure 4A ). In this process, the genome of the resultant embryos combines genomic material from the oocyte and the sperm-originated AG-haESC. This is similar to artificial fertilization technology, such as ICSI and round spermatid injection (ROSI), in which sperm or round spermatid is injected into oocytes, respectively. However, AG-haESCs, unlike sperm whose heads harbor oocyte-activation factors (Kuretake et al., 1996) , lack the ability to activate the oocytes. Thus, reconstituted oocytes from ICAHCI were activated in medium containing Sr 2+ as in standard mouse NT Wakayama et al., 1998 Wakayama et al., , 1999 Yang et al., 2010) . In a preliminary experiment, small cells, which were surmised to be in the G1 phase (Wakayama et al., 1998 (Wakayama et al., , 1999 , or FACS-selected haploid cells at the G1 phase were used as donors for injection. We found that most injected oocytes could not develop to the blastocyst stage in vitro (Table  S3) . Because oocytes that are reconstructed using metaphase ESCs as a donor develop into blastocysts at significantly higher rates than interphase ESCs in nuclear transfer experiments (Ono et al., 2001a (Ono et al., , 2001b , we synchronized AG-haESCs at metaphase and selected small cells, most of which were haploid cells in M phase, for ICAHCI. We observed that the injected haES nucleus formed a pseudopronucleus that underwent reprogramming like a male pronucleus ( Figure 4B ) (Gu et al., 2011) . Moreover, the second polar body (PB) and the pseudopolar body (PPB) were excluded from the spindle-chromosome complex and the donor metaphase nucleus, respectively, resulting in a reconstructed embryo containing diploid DNA. Injected oocytes developed into blastocysts at a rate of 51% ( Figure 4C and Table  S3 ), similar to that in control ICSI experiments (Table S3) . To examine whether these blastocysts had a normal euploid karyotype, we analyzed 19 ESC lines established from 40 blastocysts by measuring their DNA content using FACS. Seventeen ESC lines were diploid ( Figure S4A and Table S4 ), reflecting a successful ICAHCI procedure. The other two cell lines were triploid ( Figure S4A and Table S4 ), suggesting that a few diploidized AG-haESCs had been erroneously selected for injection. We next tested the developmental potential of these ICAHCI embryos by transferring two-cell embryos or blastocysts into oviducts or uteri of pseudopregnant females, respectively. Out of 553 transferred two-cell embryos and 424 blastocysts derived from all five AG-haESC lines (passage 7 to passage 22), a total of 46 live pups were recovered by caesarean section (C section) at 19.5 days of gestation (Figures 4D and S4B and Table 1 ). All of them were females, as expected from the injection of X-bearing AG-haESCs. Genotyping revealed that they carried the EGFP transgene that originated from the AG-haESCs ( Figure S4C ). We refer to these mice as semicloned (SC) (Yanagimachi, 2005; Yi et al., 2009 ) because they were derived by combining an AG-haESC donor with a normal oocyte. The rate of SC mice born was 4.5% of the transferred blastocysts or 4.9% of the transferred two-cell embryos (Table 1) , similar to the rate of standard NT using conventional ESCs (Li and Mombaerts, 2008; Wakayama et al., 1999) . However, differing from cloned mice generated from ESCs that display an overgrowth phenotype , SC mice were either normal with a typical newborn body weight or developmentally retarded ( Figures 4D, 4E , and S4B). All retarded pups died within 1 hr of birth, reminiscent of what has been observed in bimaternal mice generated by the construction of oocytes from fully grown oocytes and nongrowing oocytes that contain a single deletion of the H19 DMR (Kono et al., 2004) or double deletions of the H19 DMR and the Dlk1-Dio3 intergenic germline-derived DMR (Kawahara et al., 2007) . We then examined the methylation status of imprinted genes at birth and observed that methylation was absent at the H19 DMR in growth-retarded mice, whereas it was normal in alive newborn mice ( Figures 4F and S5A-S5C) . Interestingly, growth-retarded pups were obtained at a higher frequency from ICAHCI using the cells of later passages (from AGH-OG-3, Table 1 ) that harbored a more severe loss of the H19 methylation imprint ( Figure S3E ). Consistently, gene expression analysis showed that normal SC mice had similar expression patterns to control mice in two pairs of interrelated imprinted genes (Igf2 and H19, and Dlk1 and Gtl2), whereas growthretarded pups exhibited a significantly lower Igf2 expression in major organs than control mice ( Figure S5D ).
Normal-weight SC pups were successfully nursed by foster mothers, and most of them (14/18) grew to adulthood ( Figure 4G ). To test whether the SC mice could deliver the Oct4-EGFP transgene to the next generation by germline transmission, we dissected one newborn and one 4-week-old SC pup derived from AGH-OG-1 and observed that ovaries and germinal vesicle (GV) oocytes were EGFP positive ( Figure 5A ). Furthermore, one SC mouse, which was superovulated and mated with a normal B6D2F1 male, delivered a litter of 16 pups ( Figure 5B ). Oct4-EGFP-positive pups accounted for 50% (8/16), conforming to the expected Mendelian ratio ( Figure 5C ), as the SC mother was heterozygous for Oct4-EGFP. Importantly, transgene-positive pups were found among both female and male progeny (Figure 5D ), indicating that female SC mice derived from AG-haESCs are capable of normal gametogenesis. These data demonstrate that AG-haESCs, when injected into oocytes, can introduce genetic traits into the resulting SC mice, who further transmit to offspring.
Gene Targeting in AG-haESCs
Having demonstrated the developmental potential of AGhaESCs by both blastocyst injection and ICHACI, we next examined whether specific genetic alterations can be introduced into these haESCs through homologous recombination. To avoid potential perturbation in cellular function, a conditional gene targeting strategy was used to modify the locus of Vwce, a gene encoding a ''von Willebrand factor C and EGF domains''-containing protein presumably involved in the Wnt-signaling pathway (Du et al., 2010) . The targeting construct contains a left and a right homologous arm of 4.9 and 5.6 kb, respectively, flanking a PGK-neo drug selection cassette and a genomic region of 3.5 kb encompassing exons 2-4 ( Figure 6A ). Upon electroporation with the linearized construct, cells were selected in G418 and ganciclovir for gene targeting. Control experiments, in which cells were selected only in G418, indicated an average of a 6-fold enrichment with the G418/ganciclovir double-selection regime. When 90 double-resistant colonies, derived from two separate experiments, were analyzed by PCR using primer pairs P1-P2 and P3-P4, 43 positive clones were found ( Figure 6B ). Among these, 12 clones (13%) were identified to contain only the targeted allele, whereas the rest had an additional wild-type allele, as judged on the PCR result from the primer pair P5-P6. From four randomly picked targeted clones, AG-haESC lines (referred to as AGH-Vwce) were established through consecutive passages, followed by FACS sorting for haploid cells (Figure 6C) . The identification of stable clones that contain a significant haploid subpopulation carrying the targeted allele but lacking the wild-type allele indicates that homologous recombination has occurred in haploid cells following electroporation of the targeting construct and thus that AG-haESCs are amenable to standard gene targeting manipulation.
We next tested whether the gene-targeted AG-haESCs have the capacity to support full-term embryo development. We constructed 444 embryos via ICAHCI using Vwce-targeted AGhaESCs, and from these embryos, we obtained one live-birth SC pup ( Figure S6A ). Genotype analysis confirmed the existence of the targeted allele in the whole body of the pup ( Figure S6B ). Unfortunately, the pup was growth retarded and died shortly after birth, which might be expected considering the loss of H19 imprint in the pup and in the original Vwce-targeted AG-haESCs ( Figure S6C ). The overall low success rate of obtaining live-birth gene-targeted pups is mostly likely due to the loss of imprint (including the H19 locus) in the Vwce-targeted AG-haESCs, which represented a late-passage line (passage 28) and had been through an additional period of culturing due to selection of the targeted allele. Nevertheless, our results provide the proof of principle that genetically modified animals can be obtained via the ICAHCI technology using AG-haESCs that harbor a modified allele.
DISCUSSION
Recently, two independent groups (Elling et al., 2011; Leeb and Wutz, 2011 ) have established haESCs from mouse embryos, (D) Germline contribution of AG-haESC in both sexes of offspring of the SC mother. Two left panels show the Oct4-EGFP transgene expression in seminiferous tubules of a 1-week-old male F2 pup. Oct4 expression is detected in the entire population of gonocytes in this newborn male, as expected (Pesce et al., 1998) . The two right panels show Oct4-EGFP reporter expression in GV oocytes isolated from the ovary of a 2-week-old female F2 pup. The EGFP signal recapitulates the Oct4 expression in developing oocytes. Scale bars, 100 mm.
enabling functional screening for genes involved in diverse cellular and developmental processes (Schimenti, 2011) . In both reports, haESCs were generated from parthenogenetic blastocysts, implying that these cells probably maintain a maternal imprinting status that is established during oogenesis. If such is the case, then these haESCs may not support full-term development of embryos after injection into MII oocytes because the resulting embryos are parthenogenetic and would fail to develop to term (McGrath and Solter, 1984; Surani and Barton, 1983; Surani et al., 1984 Surani et al., , 1990 . The possible strategies to generate mice from parthenogenetic haESCs are either to replace the chromosome-spindle complex (CSC) of MII oocytes with that from haESCs, followed by ICSI into reconstituted oocytes (Liu et al., 2001 ), or to inject haESC into diploid blastocysts to derive chimeric mice with germline transmission. However, these strategies are technically complicated or have not been successfully tested (Elling et al., 2011; Leeb and Wutz, 2011) . This leaves an open question of whether haESCs can be converted into mouse models (Schimenti, 2011) , which is a prerequisite for extending genetic analysis at the cellular level to the organism level. In our study, we generated multiple haESC lines from androgenetic blastocysts and demonstrated that AG-haESCs could be used to support full-term embryonic development following injection into oocytes, which results in successful trait transmission into live animals.
During normal fertilization, a sperm carrying paternal imprints enters an egg with maternal imprints, resulting in a new organism. However, both parthenogenetic and androgenetic embryos fail to develop to term (McGrath and Solter, 1984; Surani and Barton, 1983; Surani et al., 1984 Surani et al., , 1990 , showing that completion of embryogenesis requires the contribution of both the male and the female gamete genomes of different parental imprints. AG-haES cell lines, derived from sperm, are capable of ''fertilization'' of oocytes and can be used in place of sperm to support full-term development of mouse embryos after injection into oocytes, presumably thanks to the maintenance of typical male imprinting status in these cells. The efficiency of SC mice derivation by ICAHCI is lower than that of ICSI, suggesting that differences in epigenetic features, including parental methylation imprints, exist between AG-haESCs and sperm. Further investigation into the underlying differences will not only aid our understanding of the early reprogramming events following natural fertilization, but may also yield clues to improve the sperm-like features of AG-haESCs for more efficient generation of SC animals via ICAHCI.
SC mice fall into two readily distinguishable groups based on the birth weight of pups and placentas: the growth-retarded mice that could not survive the early postnatal period and those with normal birth size that could grow to adulthood and establish fertility. A plausible interpretation is that AG-haESCs used for ICAHCI are a heterogeneous population containing both epigenetically normal cells functionally equivalent to a mature sperm and aberrant cells carrying errors in genomic imprinting that are less compatible with embryonic and/or postnatal development. This distinction of subpopulations is indeed reflected by the methylation variation at the H19-imprinted gene seen in AG-haESCs ( Figures 3C and S3) . Consistently, the smaller SC pups born from ICAHCI are characterized by hypomethylation at H19, whereas the mice with normal size are marked with the expected paternal methylation (Figures 4F and S5) . It is known that the in vitro culture environment can cause alterations in the imprinting status of H19 in human (Rugg-Gunn et al., 2007) and mouse diploid ESCs (Humpherys et al., 2001) , especially during prolonged passaging (Rugg-Gunn et al., 2005) , and that abnormal imprinting would result in aberrant development of ESC-derived embryos (Dean et al., 1998) . Therefore, a future task is to define appropriate derivation and culture conditions that would enable the relatively stable maintenance of imprinting marks in AG-haESCs, which would facilitate the potential Correctly targeted haESC clones would give rise to a 4.9 kb fragment using primers one and two (from the region spanning the left arm) and a 5.6 kb fragment using primers three and four (from the region spanning the right arm). Diploid targeting can be detected by using primers P5-P6 as an additional shorter product and would arise from the untargeted wild-type allele lacking the right loxP site. AG-haESCs from AGH-EG-1 (passage 28) were used for gene targeting. applications of these cells. One intriguing application is the generation of gene-modified animals via ICAHCI in other species for which conventional ESCs can be obtained but fail to support the production of chimeras (and thus, gene-modified animals), such as the monkey (Tachibana et al., 2012) .
In summary, we have demonstrated that the AG-haESCs can be used as a genetically tractable fertilization agent for yielding live-born mice via injection into oocytes (the ICAHCI technology). By being amenable to gene manipulations and supporting transmission of genetic information to offspring, these haploid cells open new avenues for the generation of genetically modified animals. The next challenge is to improve the sperm-like features of the AG-haESCs by optimizing their epigenetic makeup without compromising their genetic integrity and proliferative capacity.
EXPERIMENTAL PROCEDURES Animal Use and Care
All animal procedures were performed under the ethical guidelines of the Institute of Biochemistry and Cell Biology.
Preparation of AG-Haploid Embryos
Spermatozoa of Oct4-EGFP transgenic male mice (C57BL/6 background) were collected and prepared for ICSI according to the methods performed previously (Kimura and Yanagimachi, 1995; Yang et al., 2011) . B6D2F1 (C57BL/6 X DBA2) female mice were used as oocyte donors. To generate AG-haploid embryos, we used two strategies. In the first strategy, standard NT Wakayama et al., 1998) was performed, in which somatic donors were replaced by sperm heads. Briefly, oocytes were obtained 14 hr after human chorionic gonadotropin injection and enucleated in a droplet of HEPES-CZB medium containing 5 mg/ml cytochalasin B (CB) using a blunt Piezo-driven pipette. After enucleation, a single sperm head was injected into oocyte cytoplasts. The reconstructed oocytes were cultured in CZB medium for 1 hr and then activated for 5-6 hr in activation medium containing 10 mM Sr 2+ . Following activation, all of the reconstructed embryos were cultured in potassium simplex optimization medium (KSOM) with amino acids at 37 C under 5% CO 2 in air. In the second strategy, B6D2F1 female mice were mated with Actin-EGFP transgenic male mice (C57BL/6 background), and zygotes were harvested at PN3 stage. Female pronuclei, which were distinguished from male pronuclei on the basis of their size and distance from the polar body, were removed from zygotes of PN3-4 stages by piercing the zona pellucida using Piezo drive (Prime Tech) and aspirating using a micromanipulator (Gu et al., 2011) . The zygotes containing a male pronucleus were cultured in KSOM with amino acids at 37 C under 5% CO 2 in air. The reconstructed embryos that reached the morula or blastocyst stage by 3.5 days in culture were transferred to ES cell medium.
Derivation of AG-haESCs
Morulas or blastocysts were selected to generate ES cell lines as described (Yang et al., 2010) . The zona pellucida was removed using acid Tyrode solution. Each embryo was transferred into one well of a 96-well plate seeded with ICR embryonic fibroblast feeders in ESC medium supplemented with 20% knockout serum replacement, 1,500 U/ml leukemia inhibitory factor (LIF), 3 M CHIR99021, and 1 M PD0325901 (Leeb and Wutz, 2011; Ying et al., 2008) . After 4-5 days in culture, the colonies were trypsinized and transferred to a 96-well plate with a fresh feeder layer in fresh medium. Clonal expansion of the ESCs proceeded from 48-well plates to 6-well plates with feeder cells and then to 6-well plates for routine culture. To sort haploid cells, ESCs were trypsinized, washed by Dulbecco's Phosphate-Buffered Saline (GIBCO), and then incubated with 15 mg/ml Hoechst 33342 in a 37 C water bath. Subsequently, the haploid 1n peak was purified using BD FACS AriaII for further culturing. For analysis, after fixation in 70% ethanol, cells were digested by 20 mg/ml RNase A and stained with 50 mg/ml propidium iodide (PI). Analytic flow profiles were recorded by BD LSRII SORP.
Karyotype Analysis
ESCs were incubated with 0.4 mg/ml demecolcine (Sigma) for 1 hr. After trypsinizaiton, the ESCs were resuspended in 0.075 M KCl at 37 C for 30 min.
Hypotonic solution-treated cells were fixed in methanol:acetic acid (3:1 in volume) for 30 min and dropped onto precleaned slides. After being incubated in 5 M HCl, cells were stained with Giemsa for 15 min. More than ten metaphase spreads were analyzed.
Immunostaining Cells on glass coverslips were fixed in PBS supplemented with 4% paraformaldehyde for 15 min at room temperature (RT). The cells were then permeabilized using 0.2% Triton X-100 in PBS for 15 min at RT. The cells were blocked for 30 min in 1% BSA in PBS. All primary antibodies against Oct4 (sc-5279, Santa Cruz), Nanog (RCAB002P-F, Reprocell), SSEA-1 (mab4301, Millipore), and Sox2 (ab5603, Millipore) were diluted in the same blocking buffer and incubated with the samples overnight at 4 C. The cells were treated with a fluorescently coupled secondary antibody and then incubated for 1 hr at RT. The nuclei were stained with Hoechst 33342 (Sigma) for 5 min at RT.
Injection of AG-haESCs into Diploid Blastocysts
Blastocyst injection was performed as described previously (Jiang et al., 2011) . Briefly, diploid blastocysts were collected from the uteri of superovulated ICR females at 3.5 days postcoitum (dpc) and kept in KSOM medium with amino acids until haESCs injection. Prior to blastocyst injection, AG-haESCs were trypsinized, resuspended in Dulbecco's modified Eagle's medium without LIF, and kept on ice. A flat-tip microinjection pipette was used for the ES cell injection. More than 100 ESCs were picked up at the end of the injection pipette, and about 10-15 ESCs were injected into the blastocyst cavity. The blastocysts were kept in KSOM with amino acids until embryo transfer. Eight to ten injected blastocysts were transferred into each uterine horn of 2.5 dpc of pseudopregnant ICR females. Pregnant recipients were subjected to caesarean section on day 19.5 of gestation.
DNA Content Analysis of Cells from Chimeras
Chimeric fetuses generated by injection of AGH-EG-1 into diploid blastocysts were dissected at days 6.5, 8.5, 10.5, and 13.5 of gestation. Dissociation to single cells was performed by treatment with 0.05% trypsin/EDTA at 37 C for 30 min. Cells were fixed in 4% PFA in 4 C, following Hochest 33342 staining. EGFP-positive and EGFP-negative cells were isolated by FACS, and DNA content was determined by flow analysis. For FACS, a DAPI filter (for the Hoechst staining signal) and a FITC filter (for GFP) were used.
Quantitative Reverse Transcription PCR Total RNA was isolated from the cells using Trizol reagent (Invitrogen). One microgram of total RNA was reverse transcribed using a First Strand cDNA Synthesis kit (TOYOBO). Real-time quantitative PCR reactions were set up in triplicate using the SYBR Green Realtime PCR Master Mix (TOYOBO) and run on a Bio-Rad CFX96. All of the gene expression levels were normalized to the internal standard gene, Gapdh. Primer information is presented in Table S5 .
Bisulphite Sequencing
To obtain mouse sperm DNA and tail genomic DNA, samples were pretreated with dithiothreitol for 3 hr (for sperm only), following proteinase K lysis and phenol-chloroform extraction. For DNA methylation analysis in FACS-derived AG-haESCs, cumulus cells, and oocytes, bisulphite conversion was performed in agarose beads as described (Hajkova et al., 2002) . The PCR products were cloned into pMD19-T vectors (Takara), and individual clones were sequenced by Invitrogen, Shanghai. Bisulphite primer information is presented in Table S5 .
Intracytoplasmic AG-haESCs Injection
To generate SC embryos, AG-haESCs at G1 or M stage were used for intracytoplasmic injection. AG-haESCs were trypsinized, washed three times with HEPES-CZB medium, and suspended in HEPES-CZB medium containing 3% (w/v) polyvinylpyrrolidone. In the first set of experiments, small AGhaESCs, which were presumably at G1 stage or FACS-derived G1 phase AG-haESCs, were selected for injection. In the second set of experiments, AG-haESCs were arrested at M phase by culturing in medium containing 0.05 mg/ml demecolcine for 8 hr. Each nucleus from G1 phase donor cells or M phase chromosomes from M phase cells was injected into an MII-arrested oocyte using a Piezo-drill micromanipulator. The reconstructed oocytes were cultured in CZB medium for 1 hr and then activated for 5-6 hr in activation medium without CB. Following activation, all of the reconstructed embryos were cultured in KSOM medium with amino acids at 37 C under 5% CO2 in air.
Embryo Transfer and Cesarean Section ICAHCI embryos were cultured in KSOM medium until the two-cell stage or blastocyst stage. Thereafter, 15-20 two-cell embryos or 8-10 blastocysts were transferred into each oviduct or uterus of pseudopregnant ICR females at 0.5 dpc or 2.5 dpc, respectively. Recipient mothers were euthanized at 19.5 days of gestation, and the pups were quickly removed from the uteri. After cleaning fluid from their air passages, the pups were kept in a warm box supplied with oxygen. Surviving pups were raised by lactating mothers.
Microarray Analysis
RNA from biological triplicates of diploid ESCs (E14), five independently derived haploid ESCs (AGH-OG-1 passage 14, AGH-OG-2 passage 15, AGH-OG-3 passage 12, AGH-OG-4 passage 14, and AGH-EG-1 passage 15), and duplicates of mouse embryonic fibroblasts (MEFs) from male individuals were extracted using the RNeasy kit (QIAGEN). Gene expression analysis on Affymetrix GeneChip 430 2.0 arrays was performed by Imagenes. The data were analyzed using Genespring GX software (Agilent Technologies). The labeling and hybridization were performed at the Shanghai Biochip Company according to the protocols in the Affymetrix GeneChip 3 0 IVT Express Kit User Manual. The relatedness of transcription profiles was determined by calculating the Pearson correlation coefficient (r). DNA samples (from AGH-OG-2, AGH-OG-3, and AGH-EG-1) for CGH experiments were extracted and sent to the CapitalBio Corporation (Changping District, Beijing) for CGH analysis using NimbleGen 3x720K mouse wholegenome tiling arrays with an average probe spacing of 3.5 kb. Adult male C57BL/6 kidney DNA was used as a reference.
Gene Targeting
To generate the Vwce targeting vector, DNA fragments for the 5 0 and 3 0 homology arms were cloned from a BAC clone from mouse (C57BL/6) genomic DNA by the standard recombineering (recombination-mediated genetic engineering) technique. The left arm consisted of a 4.9 kb 5 0 region (including exon 1), and the right arm was a 5.6 kb fragment covering the 3 0 coding region of exons 5 and 6. The two arms were confirmed by sequencing. The AG-EG-1 haES cell line (passage 25) was used for gene targeting. Approximately 3 hr after a medium change, the ESCs were trypsinized and resuspended as a single-cell suspension at a density of 1 3 10 7 cell/ml in the Ca 2+ /Mg 2+ -free PBS and then electroporated with 25 mg of the pL253-Vwce targeting vector in a 0.4 cm wide sterile cuvette. The condition for a typical single pulse was 260 V, 500 mF. After storing at room temperature for 5 min, the cells were plated on a 10 cm dish with neomycin-resistant MEF feeder cells. After 24 hr, drug selection was started by replacing medium with ES selection medium containing about 200 mg/ml G418 and 2 mM ganciclovir, and the selection medium was changed every day. Colonies were picked 10-12 days later. The harvested colonies were trypsinized and transferred to a 24-well plate with ES selection medium containing 100 mg/ml of G418 and 2 mM of ganciclovir. After 3-5 days in culture, G418-resistant colonies were screened for homologous recombination by long-range PCR using primers (P1-4) spanning the left and right recombination arms, respectively. The primer sequences are listed in Table S5 .
Statistic Analysis
Differences of gene expression levels between groups were analyzed by means of Student's t test. All statistical analyses were done applying SPSS software 13.0.
ACCESSION NUMBERS
Gene expression and CGH data sets can be accessed as the GEO reference series GSE35787 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE35787). This series includes the GSE35785 (mRNA expression data from AG-haESC, E14, and MEF) and the GSE35786 (CGH analysis of AG-haESCs) data sets.
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